240 related articles for article (PubMed ID: 19127333)
1. A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate.
Kia EB; Rahimi HR; Mirhendi H; Nilforoushan MR; Talebi A; Zahabiun F; Kazemzadeh H; Meamar AR
Korean J Parasitol; 2008 Dec; 46(4):261-3. PubMed ID: 19127333
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
[TBL] [Abstract][Full Text] [Related]
3. Strongyloides hyperinfection syndrome complications: a case report and review of the literature.
Najmuddin A; Hadique S; Parker J
W V Med J; 2012; 108(1):32-8. PubMed ID: 25134190
[TBL] [Abstract][Full Text] [Related]
4. A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review.
Qu TT; Yang Q; Yu MH; Wang J
Medicine (Baltimore); 2016 May; 95(19):e3638. PubMed ID: 27175679
[TBL] [Abstract][Full Text] [Related]
5. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
[TBL] [Abstract][Full Text] [Related]
6. Case Report:
Guerrero-Wooley R; Aranda-Aguirre E; Li W; Wilkin A; Palavecino E
Am J Trop Med Hyg; 2017 Nov; 97(5):1629-1631. PubMed ID: 29140240
[No Abstract] [Full Text] [Related]
7.
Pedersen AA; Hartmeyer GN; Stensvold CR; Martin-Iguacel R
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36137646
[TBL] [Abstract][Full Text] [Related]
8. Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome.
El-Sameed YA; Beejay N; Al Maashari R
Clin Respir J; 2015 Oct; 9(4):489-92. PubMed ID: 24902477
[TBL] [Abstract][Full Text] [Related]
9. Management of Strongyloides stercoralis: a puzzling parasite.
Luvira V; Watthanakulpanich D; Pittisuttithum P
Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis.
Hennessey DC; Ballesteros ÓA; Merchán DJ; Guevara FO; Severiche DF
Biomedica; 2020 Jun; 40(2):228-232. PubMed ID: 32673452
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.
Boodman C; Chhonker YS; Murry DJ; Mah A; Grant J; Steiner T; Libman M; Nishi C; Charles M
Am J Trop Med Hyg; 2018 Nov; 99(5):1194-1197. PubMed ID: 30226142
[TBL] [Abstract][Full Text] [Related]
12. Management of severe strongyloidiasis attended at reference centers in Spain.
Martinez-Perez A; Roure Díez S; Belhassen-Garcia M; Torrús-Tendero D; Perez-Arellano JL; Cabezas T; Soler C; Díaz-Menéndez M; Navarro M; Treviño B; Salvador F;
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006272. PubMed ID: 29474356
[TBL] [Abstract][Full Text] [Related]
13. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
14.
Mishra S; Patnayak R; Panda SS; Jena A
J Postgrad Med; 2021; 67(2):113-114. PubMed ID: 33835056
[No Abstract] [Full Text] [Related]
15. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
16. [An overview of Strongyloides stercoralis and its infections].
Ardiç N
Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
[TBL] [Abstract][Full Text] [Related]
17. Case Report: Challenges for the Diagnosis and Treatment of Strongyloides stercoralis in Chronic Obstructive Pulmonary Disease Patients.
Ashiri A; Rafiei A; Beiromvand M; Khanzadeh A; Alghasi A
Am J Trop Med Hyg; 2021 Nov; 106(2):695-699. PubMed ID: 34844210
[TBL] [Abstract][Full Text] [Related]
18. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.
Hauber HP; Galle J; Chiodini PL; Rupp J; Birke R; Vollmer E; Zabel P; Lange C
Infection; 2005 Oct; 33(5-6):383-6. PubMed ID: 16258873
[TBL] [Abstract][Full Text] [Related]
19. Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient.
Rodriguez-Hernandez MJ; Ruiz-Perez-Pipaon M; Cañas E; Bernal C; Gavilan F
Am J Transplant; 2009 Nov; 9(11):2637-40. PubMed ID: 19843038
[TBL] [Abstract][Full Text] [Related]
20. Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review.
Miskovic R; Plavsic A; Bolpacic J; Raskovic S; Ranin J; Bogic M
Rheumatol Int; 2018 Dec; 38(12):2315-2321. PubMed ID: 30353268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
